PerkinElmer, Inc. (PKI) Tops Q1 EPS by 2c; Boosts FY12 EPS Outlook
Tweet
Share
E-mailGet Alerts PKI Hot Sheet
Price: $115.24 --0%
Financial Fact:
Net income from continuing operations: 57.75M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Net income from continuing operations: 57.75M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
PerkinElmer, Inc. (NYSE: PKI) reported Q1 EPS of $0.43, $0.02 better than the analyst estimate of $0.41. Revenue for the quarter came in at $511 million versus the consensus estimate of $508.86 million.
PerkinElmer, Inc. sees FY2012 EPS of $2.00-$2.05, versus prior guidance of $1.98-$2.04 and the consensus of $2.03.
For earnings history and earnings-related data on PerkinElmer, Inc. (PKI) click here.
PerkinElmer, Inc. sees FY2012 EPS of $2.00-$2.05, versus prior guidance of $1.98-$2.04 and the consensus of $2.03.
For earnings history and earnings-related data on PerkinElmer, Inc. (PKI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 4c ; Offers Guidance
- Stratasys (SSYS) Tops Q2 EPS by 2c ;; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
